MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Buys 14,489 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,665 shares of the healthcare conglomerate’s stock after acquiring an additional 14,489 shares during the period. UnitedHealth Group accounts for 2.1% of MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s investment portfolio, making the stock its 10th largest holding. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in UnitedHealth Group were worth $59,198,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Bell Investment Advisors Inc increased its stake in shares of UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC raised its holdings in shares of UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares during the period. Verdence Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 2.1% in the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after buying an additional 342 shares during the period. Austin Private Wealth LLC boosted its holdings in UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares in the last quarter. Finally, Bellecapital International Ltd. increased its holdings in shares of UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after acquiring an additional 193 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Barclays increased their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. TD Cowen lowered their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, Bank of America reiterated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $498.13 on Wednesday. The firm has a market capitalization of $458.47 billion, a PE ratio of 30.45, a P/E/G ratio of 1.48 and a beta of 0.60. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average price of $498.40 and a two-hundred day moving average price of $501.35. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the business posted $6.26 earnings per share. The business’s quarterly revenue was up 8.6% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.69%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.